Mitochondrial remodeling: Rearranging, recycling, and reprogramming

Cell Calcium

Volumn 60, Issue 2, 2016, Pages 88-101

  Gottlieb, Roberta A ^a   Bernstein, Daniel ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Biogenesis; Fission; Fusion; Metabolism; Mitochondria; Mitochondrial unfolded protein response; Mitophagy; Retrograde signaling

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; CALCIUM; FATTY ACID; GLUCOSE; MITOCHONDRIAL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; PARKIN; PHOSPHOTRANSFERASE; PROTEOME; PTEN INDUCED PUTATIVE KINASE 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; APOPTOSIS; CALCIUM CELL LEVEL; CELL NUCLEUS; CELL PH; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOSOL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; LIPID PEROXIDATION; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL FISSION; MITOCHONDRIAL FUSION; MITOCHONDRIAL GENOME; MITOCHONDRIAL REMODELING; MITOPHAGY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; ANIMAL; METABOLISM; MITOCHONDRION;

ANIMALS; APOPTOSIS; CELL NUCLEUS; HUMANS; MITOCHONDRIA; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; REACTIVE OXYGEN SPECIES;

EID: 84964627159     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2016.04.006     Document Type: Review

References (219)

1. [1] Lewis, M.R., Lewis, W.H., Mitochondria (and other cytoplasmic structures) in tissue cultures. Am. J. Anat. 17 (1915), 339–401.
2. [2] Lewis, M.R., Lewis, W.H., Mitochondria in tissue culture. Science 39 (1914), 330–333.
3. [3] Yoon, Y., Krueger, E.W., Oswald, B.J., McNiven, M.A., The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol. Cell. Biol. 23 (2003), 5409–5420.
4. [4] Stojanovski, D., Koutsopoulos, O.S., Okamoto, K., Ryan, M.T., Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology. J. Cell Sci. 117 (2004), 1201–1210.
5. [5] James, D.I., Parone, P.A., Mattenberger, Y., Martinou, J.C., hFis1, a novel component of the mammalian mitochondrial fission machinery. J. Biol. Chem. 278 (2003), 36373–36379.
6. [6] Smirnova, E., Griparic, L., Shurland, D.L., van der Bliek, A.M., Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 12 (2001), 2245–2256.
7. [7] Otera, H., Wang, C., Cleland, M.M., Setoguchi, K., Yokota, S., Youle, R.J., Mihara, K., Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191 (2010), 1141–1158.
8. [8] Kim, H., Scimia, M.C., Wilkinson, D., Trelles, R.D., Wood, M.R., Bowtell, D., Dillin, A., Mercola, M., Ronai, Z.A., Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol. Cell 44 (2011), 532–544.
9. [9] Kaddour-Djebbar, I., Choudhary, V., Brooks, C., Ghazaly, T., Lakshmikanthan, V., Dong, Z., Kumar, M.V., Specific mitochondrial calcium overload induces mitochondrial fission in prostate cancer cells. Int. J. Oncol. 36 (2010), 1437–1444.
10. [10] Disatnik, M.-H., Ferreira, J.C.B., Campos, J.C., Gomes, K.S., Dourado, P.M.M., Qi, X., Mochly-Rosen, D., Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J. Am. Heart Assoc., 2, 2013, e000461.
11. [11] Guo, X., Disatnik, M.H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., Qi, X., Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J. Clin. Invest. 123 (2013), 5371–5388.
12. [12] Qi, X., Qvit, N., Su, Y.C., Mochly-Rosen, D., A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 126 (2013), 789–802.
13. [13] Gandre-Babbe, S., van der Bliek, A.M., The novel tail-anchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. Mol. Biol. Cell 19 (2008), 2402–2412.
14. [14] Otera, H., Mihara, K., Molecular mechanisms and physiologic functions of mitochondrial dynamics. J. Biochem. 149 (2011), 241–251.
15. [15] Zhao, J., Liu, T., Jin, S., Wang, X., Qu, M., Uhlen, P., Tomilin, N., Shupliakov, O., Lendahl, U., Nister, M., Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J. 30 (2011), 2762–2778.
16. [16] Santel, A., Frank, S., Shaping mitochondria: the complex posttranslational regulation of the mitochondrial fission protein DRP1. IUBMB Life 60 (2008), 448–455.
17. [17] Chang, C.R., Blackstone, C., Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. N. Y. Acad. Sci. 1201 (2010), 34–39.
18. [18] Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., Mihara, K., Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282 (2007), 11521–11529.
19. [19] Cribbs, J.T., Strack, S., Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8 (2007), 939–944.
20. [20] Chang, C.R., Blackstone, C., Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J. Biol. Chem. 282 (2007), 21583–21587.
21. [21] Han, X.J., Lu, Y.F., Li, S.A., Kaitsuka, T., Sato, Y., Tomizawa, K., Nairn, A.C., Takei, K., Matsui, H., Matsushita, M., CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J. Cell Biol. 182 (2008), 573–585.
22. [22] Harder, Z., Zunino, R., McBride, H., Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr. Biol. 14 (2004), 340–345.
23. [23] Braschi, E., Zunino, R., McBride, H.M., MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Rep. 10 (2009), 748–754.
24. [24] Figueroa-Romero, C., Iniguez-Lluhi, J.A., Stadler, J., Chang, C.R., Arnoult, D., Keller, P.J., Hong, Y., Blackstone, C., Feldman, E.L., SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J. 23 (2009), 3917–3927.
25. [25] Cho, D.H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., Lipton, S.A., S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324 (2009), 102–105.
26. [26] Wang, H., Song, P., Du, L., Tian, W., Yue, W., Liu, M., Li, D., Wang, B., Zhu, Y., Cao, C., et al. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J. Biol. Chem. 286 (2011), 11649–11658.
27. [27] Karbowski, M., Neutzner, A., Youle, R.J., The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J. Cell Biol. 178 (2007), 71–84.
28. [28] Nakamura, N., Kimura, Y., Tokuda, M., Honda, S., Hirose, S., MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep. 7 (2006), 1019–1022.
29. [29] Kasahara, A., Cipolat, S., Chen, Y., Dorn, G.W. 2nd, Scorrano, L., Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science 342 (2013), 734–737.
30. (2+) crosstalk. Circ. Res. 111 (2012), 863–875.
31. [31] Anand, R., Wai, T., Baker, M.J., Kladt, N., Schauss, A.C., Rugarli, E., Langer, T., The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J. Cell Biol. 204 (2014), 919–929.
32. [32] Ishihara, N., Fujita, Y., Oka, T., Mihara, K., Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 25 (2006), 2966–2977.
33. [33] Wai, T., Garcia-Prieto, J., Baker, M.J., Merkwirth, C., Benit, P., Rustin, P., Ruperez, F.J., Barbas, C., Ibanez, B., Langer, T., Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science, 350, 2015, aad0116.
34. [34] Zhao, J., Lendahl, U., Nister, M., Regulation of mitochondrial dynamics: convergences and divergences between yeast and vertebrates. Cell. Mol. Life Sci. 70 (2013), 951–976.
35. [35] Twig, G., Elorza, A., Molina, A.J., Mohamed, H., Wikstrom, J.D., Walzer, G., Stiles, L., Haigh, S.E., Katz, S., Las, G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27 (2008), 433–446.
36. [36] Ong, S.-B., Subrayan, S., Lim, S.Y., Yellon, D.M., Davidson, S.M., Hausenloy, D.J., Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121 (2010), 2012–2022.
37. [37] Chen, L., Gong, Q., Stice, J.P., Knowlton, A.A., Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc. Res. 84 (2009), 91–99.
38. [38] Yu, T., Sheu, S.S., Robotham, J.L., Yoon, Y., Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res. 79 (2008), 341–351.
39. [39] Qi, X., Disatnik, M.H., Shen, N., Sobel, R.A., Mochly-Rosen, D., Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Mol. Biol. Cell 22 (2011), 256–265.
40. [40] Crescenzo, R., Lionetti, L., Mollica, M.P., Ferraro, M., D'Andrea, E., Mainieri, D., Dulloo, A.G., Liverini, G., Iossa, S., Altered skeletal muscle subsarcolemmal mitochondrial compartment during catch-up fat after caloric restriction. Diabetes 55 (2006), 2286–2293.
41. [41] Narendra, D., Tanaka, A., Suen, D.F., Youle, R.J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183 (2008), 795–803.
42. [42] Lee, J.Y., Nagano, Y., Taylor, J.P., Lim, K.L., Yao, T.P., Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell Biol. 189 (2010), 671–679.
43. [43] Gehrke, S., Wu, Z., Klinkenberg, M., Sun, Y., Auburger, G., Guo, S., Lu, B., PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane. Cell Metab. 21 (2015), 95–108.
44. [44] Lesnik, C., Golani-Armon, A., Arava, Y., Localized translation near the mitochondrial outer membrane: an update. RNA Biol. 12 (2015), 801–809.
45. [45] Gong, G., Song, M., Csordas, G., Kelly, D.P., Matkovich, S.J., Dorn, G.W., Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science, 350, 2015, aad2459.
46. [46] McLelland, G.L., Soubannier, V., Chen, C.X., McBride, H.M., Fon, E.A., Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 33 (2014), 282–295.
47. [47] Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., Kimura, Y., Tsuchiya, H., Yoshihara, H., Hirokawa, T., et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510 (2014), 162–166.
48. [48] Yonashiro, R., Ishido, S., Kyo, S., Fukuda, T., Goto, E., Matsuki, Y., Ohmura-Hoshino, M., Sada, K., Hotta, H., Yamamura, H., et al. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J. 25 (2006), 3618–3626.
49. [49] Karbowski, M., Youle, R.J., Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. Curr. Opin. Cell Biol. 23 (2011), 476–482.
50. [50] Dagda, R.K., Cherra, S.J. 3rd, Kulich, S.M., Tandon, A., Park, D., Chu, C.T., Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J. Biol. Chem. 284 (2009), 13843–13855.
51. [51] Lutz, A.K., Exner, N., Fett, M.E., Schlehe, J.S., Kloos, K., Lammermann, K., Brunner, B., Kurz-Drexler, A., Vogel, F., Reichert, A.S., et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J. Biol. Chem. 284 (2009), 22938–22951.
52. [52] Hamacher-Brady, A., Brady, N.R., Logue, S.E., Sayen, M.R., Jinno, M., Kirshenbaum, L.A., Gottlieb, R.A., Gustafsson, A.B., Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 14 (2007), 146–157.
53. [53] Sandoval, H., Thiagarajan, P., Dasgupta, S.K., Schumacher, A., Prchal, J.T., Chen, M., Wang, J., Essential role for Nix in autophagic maturation of erythroid cells. Nature 454 (2008), 232–235.
54. [54] Lehman, J.J., Barger, P.M., Kovacs, A., Saffitz, J.E., Medeiros, D.M., Kelly, D.P., Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106 (2000), 847–856 (JID -7802877).
55. [55] Scarpulla, R.C., Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88 (2008), 611–638.
56. [56] Wende, A.R., Schaeffer, P.J., Parker, G.J., Zechner, C., Han, D.-H., Chen, M.M., Hancock, C.R., Lehman, J.J., Huss, J.M., McClain, D.A., et al. A role for the transcriptional coactivator PGC-1α in muscle refueling. J. Biol. Chem. 282 (2007), 36642–36651.
57. 2+) and AMPK/SIRT1. Nature 464 (2010), 1313–1319.
58. [58] Schrey, M.P., Montague, W., Phosphatidylinositol hydrolysis in isolated guinea-pig islets of Langerhans. Biochem. J. 216 (1983), 433–441.
59. [59] Andersson, D.C., Fauconnier, J., Yamada, T., Lacampagne, A., Zhang, S.J., Katz, A., Westerblad, H., Mitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomycytes. J. Physiol. 589 (2011), 1791–1801.
60. [60] Zippin, J.H., Chen, Y., Nahirney, P., Kamenetsky, M., Wuttke, M.S., Fischman, D.A., Levin, L.R., Buck, J., Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB J. 17 (2003), 82–84.
61. [61] Acin-Perez, R., Salazar, E., Kamenetsky, M., Buck, J., Levin, L.R., Manfredi, G., Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab. 9 (2009), 265–276.
62. [62] Katona, D., Rajki, A., Di Benedetto, G., Pozzan, T., Spat, A., Calcium-dependent mitochondrial cAMP production enhances aldosterone secretion. Mol. Cell. Endocrinol. 412 (2015), 196–204.
63. [63] Di Benedetto, G., Scalzotto, E., Mongillo, M., Pozzan, T., Mitochondrial Ca(2)(+) uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels. Cell Metab. 17 (2013), 965–975.
64. [64] Astin, R., Bentham, R., Djafarzadeh, S., Horscroft, J.A., Kuc, R.E., Leung, P.S., Skipworth, J.R., Vicencio, J.M., Davenport, A.P., Murray, A.J., et al. No evidence for a local renin-angiotensin system in liver mitochondria. Sci. Rep., 3, 2013, 2467.
65. [65] Schwanhausser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., Selbach, M., Global quantification of mammalian gene expression control. Nature 473 (2011), 337–342.
66. [66] Cougot, N., Bhattacharyya, S.N., Tapia-Arancibia, L., Bordonne, R., Filipowicz, W., Bertrand, E., Rage, F., Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal activation. J. Neurosci. 28 (2008), 13793–13804.
67. [67] Patel, P.H., Barbee, S.A., Blankenship, J.T., GW-Bodies and P-Bodies constitute two separate pools of sequestered non-Translating RNAs. PLoS One, 11, 2016, e0150291.
68. [68] Huang, L., Mollet, S., Souquere, S., Le Roy, F., Ernoult-Lange, M., Pierron, G., Dautry, F., Weil, D., Mitochondria associate with P-bodies and modulate microRNA-mediated RNA interference. J. Biol. Chem. 286 (2011), 24219–24230.
69. [69] Cougot, N., Cavalier, A., Thomas, D., Gillet, R., The dual organization of P-bodies revealed by immunoelectron microscopy and electron tomography. J. Mol. Biol. 420 (2012), 17–28.
70. [70] Ikeda, Y., Shirakabe, A., Maejima, Y., Zhai, P., Sciarretta, S., Toli, J., Nomura, M., Mihara, K., Egashira, K., Ohishi, M., et al. Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ. Res. 116 (2015), 264–278.
71. [71] Song, M., Mihara, K., Chen, Y., Scorrano, L., Dorn, G.W., Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 21 (2015), 273–285.
72. [72] Kageyama, Y., Hoshijima, M., Seo, K., Bedja, D., Sysa-Shah, P., Andrabi, S.A., Chen, W., Hoke, A., Dawson, V.L., Dawson, T.M., et al. Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. EMBO J. 33 (2014), 2798–2813.
73. [73] Bach, D., Pich, S., Soriano, F.X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J.R., Lloberas, J., Camps, M., Zierath, J.R., et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: a novel regulatory mechanism altered in obesity. J. Biol. Chem. 278 (2003), 17190–17197.
74. [74] Chen, H., Chomyn, A., Chan, D.C., Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280 (2005), 26185–26192.
75. [75] Benard, G., Bellance, N., James, D., Parrone, P., Fernandez, H., Letellier, T., Rossignol, R., Mitochondrial bioenergetics and structural network organization. J. Cell Sci. 120 (2007), 838–848.
76. [76] Ishihara, T., Ban-Ishihara, R., Maeda, M., Matsunaga, Y., Ichimura, A., Kyogoku, S., Aoki, H., Katada, S., Nakada, K., Nomura, M., et al. Dynamics of mitochondrial DNA nucleoids regulated by mitochondrial fission is essential for maintenance of homogeneously active mitochondria during neonatal heart development. Mol. Cell. Biol. 35 (2015), 211–223.
77. [77] Chen, Y., Liu, Y., Dorn, G.W. 2nd, Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ. Res. 109 (2011), 1327–1331.
78. [78] Papanicolaou, K.N., Kikuchi, R., Ngoh, G.A., Coughlan, K.A., Dominguez, I., Stanley, W.C., Walsh, K., Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ. Res. 111 (2012), 1012–1026.
79. [79] Gottlieb, R.A., Gustafsson, A.B., Mitochondrial turnover in the heart. Biochim. Biophys. Acta 1813 (2011), 1295–1301.
80. [80] Givvimani, S., Munjal, C., Tyagi, N., Sen, U., Metreveli, N., Tyagi, S.C., Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS One, 7, 2012, e32388.
81. [81] Shields, L.Y., Kim, H., Zhu, L., Haddad, D., Berthet, A., Pathak, D., Lam, M., Ponnusamy, R., Diaz-Ramirez, L.G., Gill, T.M., et al. Dynamin-related protein 1 is required for normal mitochondrial bioenergetic and synaptic function in CA1 hippocampal neurons. Cell Death Dis., 6, 2015, e1725.
82. [82] Gottlieb, R.A., Bernstein, D., METABOLISM. Mitochondria shape cardiac metabolism. Science 350 (2015), 1162–1163.
83. [83] Enriquez, J.A., Supramolecular organization of respiratory complexes. Annu. Rev. Physiol. 78 (2016), 533–561.
84. [84] Cogliati, S., Frezza, C., Soriano, M.E., Varanita, T., Quintana-Cabrera, R., Corrado, M., Cipolat, S., Costa, V., Casarin, A., Gomes, L.C., et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155 (2013), 160–171.
85. [85] Gomes, L.C., Di Benedetto, G., Scorrano, L., During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13 (2011), 589–598.
86. [86] Wallace, D.C., Mitochondrial diseases in man and mouse. Science 283 (1999), 1482–1488.
87. [87] Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R.L., Atwood, C.S., Johnson, A.B., Kress, Y., Vinters, H.V., Tabaton, M., et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001), 3017–3023.
88. [88] Obeso, J.A., Rodriguez-Oroz, M.C., Goetz, C.G., Marin, C., Kordower, J.H., Rodriguez, M., Hirsch, E.C., Farrer, M., Schapira, A.H., Halliday, G., Missing pieces in the Parkinson's disease puzzle. Nat. Med. 16 (2010), 653–661.
89. [89] Büeler, H., Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease. Apoptosis: Int. J. Program. Cell Death 15 (2010), 1336–1353.
90. [90] Chen, H., Chan, D.C., Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet. 18 (2009), R169–176.
91. [91] Archer, S.L., Mitochondrial dynamics-mitochondrial fission and fusion in human diseases. N. Engl. J. Med. 369 (2013), 2236–2251.
92. [92] Ryan, J.J., Marsboom, G., Fang, Y.H., Toth, P.T., Morrow, E., Luo, N., Piao, L., Hong, Z., Ericson, K., Zhang, H.J., et al. PGC1alpha-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 187 (2013), 865–878.
93. [93] Zuchner, S., Mersiyanova, I.V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E.L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36 (2004), 449–451.
94. [94] Olichon, A., Guillou, E., Delettre, C., Landes, T., Arnaune-Pelloquin, L., Emorine, L.J., Mils, V., Daloyau, M., Hamel, C., Amati-Bonneau, P., et al. Mitochondrial dynamics and disease, OPA1. Biochim. Biophys. Acta 1763 (2006), 500–509.
95. [95] Song, M., Dorn, G.W. 2nd, Mitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heart. Cell Metab. 21 (2015), 195–205.
96. [96] Dorn, G.W. 2nd, Kitsis, R.N., The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble. Circ. Res. 116 (2015), 167–182.
97. [97] Ong, S.-B., Hausenloy, D.J., Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 88 (2010), 16–29.
98. [98] Beraud, N., Pelloux, S., Usson, Y., Kuznetsov, A.V., Ronot, X., Tourneur, Y., Saks, V., Mitochondrial dynamics in heart cells: very low amplitude high frequency fluctuations in adult cardiomyocytes and flow motion in non beating Hl-1 cells. J. Bioenerg. Biomembr. 41 (2009), 195–214.
99. [99] Sun, C.N., Dhalla, N.S., Olson, R.E., Formation of gigantic mitochondria in hypoxic isolated perfused rat hearts. Experientia 25 (1969), 763–764.
100. [100] Schaper, J., Froede, R., Hein, S., Buck, A., Hashizume, H., Speiser, B., Friedl, A., Bleese, N., Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83 (1991), 504–514.
101. [101] Hong, Z., Kutty, S., Toth, P.T., Marsboom, G., Hammel, J.M., Chamberlain, C., Ryan, J.J., Zhang, H.J., Sharp, W.W., Morrow, E., et al. Role of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus. Circ. Res. 112 (2013), 802–815.
102. [102] Suen, D.F., Norris, K.L., Youle, R.J., Mitochondrial dynamics and apoptosis. Genes Dev. 22 (2008), 1577–1590.
103. [103] Jeong, S.Y., Seol, D.W., The role of mitochondria in apoptosis. BMB Rep. 41 (2008), 11–22.
104. [104] Wibom, R., Hultman, E., Johansson, M., Matherei, K., Constantin-Teodosiu, D., Schantz, P.G., Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining. J. Appl. Physiol. (Bethesda Md.: 1985) 73 (1992), 2004–2010.
105. [105] Wallace, D.C., Fan, W., Procaccio, V., Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 5 (2010), 297–348.
106. [106] Feng, Z., Bai, L., Yan, J., Li, Y., Shen, W., Wang, Y., Wertz, K., Weber, P., Zhang, Y., Chen, Y., et al. Mitochondrial dynamic remodeling in strenuous exercise-induced muscle and mitochondrial dysfunction: regulatory effects of hydroxytyrosol. Free Radic. Biol. Med. 50 (2011), 1437–1446.
107. [107] Ding, H., Jiang, N., Liu, H., Liu, X., Liu, D., Zhao, F., Wen, L., Liu, S., Ji, L.L., Zhang, Y., 2010. Response of mitochondrial fusion and fission protein gene expression to exercise in rat skeletal muscle. Biochim. Biophys. Acta 25 (1800), 0–256.
108. [108] Konopka, A.R., Suer, M.K., Wolff, C.A., Harber, M.P., Markers of human skeletal muscle mitochondrial biogenesis and quality control: effects of age and aerobic exercise training. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 69 (2013), 371–378.
109. [109] Gottlieb, R.A., Carreira, R.S., Autophagy in health and disease 5. Mitophagy as a way of life. Am. J. Physiol. Cell Physiol. 299 (2010), C203–210.
110. [110] O'Neill, B.T., Kim, J., Wende, A.R., Theobald, H.A., Tuinei, J., Buchanan, J., Guo, A., Zaha, V.G., Davis, D.K., Schell, J.C., et al. A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab. 6 (2007), 294–306.
111. [111] Dworatzek, E., Mahmoodzadeh, S., Schubert, C., Westphal, C., Leber, J., Kusch, A., Kararigas, G., Fliegner, D., Moulin, M., Ventura-Clapier, R., et al. Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta. Cardiovasc. Res. 102 (2014), 418–428.
112. [112] Coronado, M., Fajardo, G., Nguyen, K., Zhao, M., Bezold Kooiker, K., Jung, G., Hu, D.-Q., Reddy, S., Sandoval, E., Stotland, A., et al. Physiologic mitochondrial fragmentation is a cardiac adaptation to increased energy demand. Circ. Res., 2015, e123.
113. [113] Dorn, G.W. 2nd, Mitochondrial dynamics in heart disease. Biochim. Biophys. Acta, 2013, 233–241.
114. [114] Pan, X., Liu, J., Nguyen, T., Liu, C., Sun, J., Teng, Y., Fergusson, M.M., Rovira, I.I., Allen, M., Springer, D.A., et al. The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat. Cell Biol. 15 (2013), 1464–1472.
115. [115] Santo-Domingo, J., Demaurex, N., Calcium uptake mechanisms of mitochondria. Biochim. Biophys. Acta 1797 (2010), 907–912.
116. [116] Lawrie, A.M., Rizzuto, R., Pozzan, T., Simpson, A.W., A role for calcium influx in the regulation of mitochondrial calcium in endothelial cells. J. Biol. Chem. 271 (1996), 10753–10759.
117. [117] Baughman, J.M., Perocchi, F., Girgis, H.S., Plovanich, M., Belcher-Timme, C.A., Sancak, Y., Bao, X.R., Strittmatter, L., Goldberger, O., Bogorad, R.L., et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476 (2011), 341–345.
118. [118] O'Rourke, B., Van Eyk, J.E., Foster, D.B., Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure. Congest. Heart Fail. 17 (2011), 269–282.
119. [119] Park, M.K., Ashby, M.C., Erdemli, G., Petersen, O.H., Tepikin, A.V., Perinuclear, perigranular and sub-plasmalemmal mitochondria have distinct functions in the regulation of cellular calcium transport. EMBO J. 20 (2001), 1863–1874.
120. [120] Marchi, S., Pinton, P., The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J. Physiol. 592 (2014), 829–839.
121. + antiporter. Science 326 (2009), 144–147.
122. [122] Carafoli, E., The fateful encounter of mitochondria with calcium: how did it happen?. Biochim. Biophys. Acta 5 (2010), 595–606.
123. 2+ exchanger in metabolically inhibited MDCK cells. Am. J. Physiol. Renal Physiol. 286 (2004), F784–794.
124. [124] Jung, D.W., Baysal, K., Brierley, G.P., The sodium-calcium antiport of heart mitochondria is not electroneutral. J. Biol. Chem. 270 (1995), 672–678.
125. 2+ exchange. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 436–441.
126. [126] Denton, R.M., Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta 130 (2009), 1309–1316.
127. 2+ ions in the regulation of intramitochondrial metabolism and energy production in rat heart. Mol. Cell. Biochem. 89 (1989), 121–125.
128. 2+ in rat ventricular myocytes. Biochim. Biophys. Acta 91 (2010), 913–921.
129. [129] Cereghetti, G.M., Stangherlin, A., Martins de Brito, O., Chang, C.R., Blackstone, C., Bernardi, P., Scorrano, L., Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 15803–15808.
130. [130] Zhang, X., Szeto, C., Gao, E., Tang, M., Jin, J., Fu, Q., Makarewich, C., Ai, X., Li, Y., Tang, A., et al. Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling. Circ. Res. 112 (2013), 498–509.
131. [131] Marsboom, G., Toth, P.T., Ryan, J.J., Hong, Z., Wu, X., Fang, Y.H., Thenappan, T., Piao, L., Zhang, H.J., Pogoriler, J., et al. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension. Circ. Res. 110 (2012), 1484–1497.
132. 2+ and NADH mediated superoxide anion dependent inhibition. Biochemistry 43 (2004), 8494–8502.
133. [133] Zhang, P., Kirk, J.A., Ji, W., dos Remedios, C.G., Kass, D.A., Van Eyk, J.E., Murphy, A.M., Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation 126 (2012), 1828–1837.
134. [134] Kirk, J.A., Zhang, P., Murphy, A.M., Van Eyk, J.E., Troponin I alterations detected by multiple-reaction monitoring: how might this impact the study of heart failure?. Expert Rev. Proteomics 10 (2013), 5–8.
135. [135] Lam, M.P., Lau, E., Scruggs, S.B., Wang, D., Kim, T.Y., Liem, D.A., Zhang, J., Ryan, C.M., Faull, K.F., Ping, P., Site-specific quantitative analysis of cardiac mitochondrial protein phosphorylation. J. Proteomics 81 (2013), 15–23.
136. [136] Lam, M.P., Scruggs, S.B., Kim, T.Y., Zong, C., Lau, E., Wang, D., Ryan, C.M., Faull, K.F., Ping, P., An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. J. Proteomics 75 (2012), 4602–4609.
137. [137] Deng, N., Zhang, J., Zong, C., Wang, Y., Lu, H., Yang, P., Wang, W., Young, G.W., Wang, Y., Korge, P., et al. Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol. Cell. Proteomics, 10, 2011 (M110 000117).
138. [138] Rosca, M.G., Vazquez, E.J., Kerner, J., Parland, W., Chandler, M.P., Stanley, W., Sabbah, H.N., Hoppel, C.L., Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc. Res. 80 (2008), 30–39.
139. [139] Chen, Q., Lin, R.Y., Rubin, C.S., Organelle-specific targeting of protein kinase AII (PKAII): Molecular and in situ characterization of murine A kinase anchor proteins that recruit regulatory subunits of PKAII to the cytoplasmic surface of mitochondria. J. Biol. Chem. 272 (1997), 15247–15257.
140. [140] Wang, S.B., Foster, D.B., Rucker, J., O'Rourke, B., Kass, D.A., Van Eyk, J.E., Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ. Res. 109 (2011), 750–757.
141. [141] Kane, L.A., Youngman, M.J., Jensen, R.E., Van Eyk, J.E., Phosphorylation of the F(1)F(o) ATP synthase beta subunit: functional and structural consequences assessed in a model system. Circ. Res. 106 (2010), 504–513.
142. [142] Agnetti, G., Kaludercic, N., Kane, L.A., Elliott, S.T., Guo, Y., Chakir, K., Samantapudi, D., Paolocci, N., Tomaselli, G.F., Kass, D.A., et al. Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ. Cardiovasc. Genet. 3 (2010), 78–87.
143. [143] Wang, S.B., Murray, C.I., Chung, H.S., Van Eyk, J.E., Redox regulation of mitochondrial ATP synthase. Trends Cardiovasc. Med. 23 (2013), 14–18.
144. [144] Rajabi, M., Kassiotis, C., Razeghi, P., Taegtmeyer, H., Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 12 (2007), 331–343.
145. [145] Lopaschuk, G.D., Ussher, J.R., Folmes, C.D., Jaswal, J.S., Stanley, W.C., Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90 (2010), 207–258.
146. [146] Paolisso, G., Gambardella, A., Galzerano, D., D'Amore, A., Rubino, P., Verza, M., Teasuro, P., Varricchio, M., D'Onofrio, F., Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism 43 (1994), 174–179.
147. [147] Lommi, J., Kupari, M., Yki-Jarvinen, H., Free fatty acid kinetics and oxidation in congestive heart failure. Am. J. Cardiol. 81 (1998), 45–50.
148. [148] Patel, M.S., Korotchkina, L.G., Regulation of the pyruvate dehydrogenase complex. Biochem. Soc. Trans. 34 (2006), 217–222.
149. [149] Roche, T.E., Baker, J.C., Yan, X., Hiromasa, Y., Gong, X., Peng, T., Dong, J., Turkan, A., Kasten, S.A., Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog. Nucleic Acid Res. Mol. Biol. 70 (2001), 33–75.
150. [150] Lu, G., Ren, S., Korge, P., Choi, J., Dong, Y., Weiss, J., Koehler, C., Chen, J.N., Wang, Y., A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development. Genes Dev. 21 (2007), 784–796.
151. [151] Abadir, P.M., Foster, D.B., Crow, M., Cooke, C.A., Rucker, J.J., Jain, A., Smith, B.J., Burks, T.N., Cohn, R.D., Fedarko, N.S., et al. Identification and characterization of a functional mitochondrial angiotensin system. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 14849–14854.
152. [152] Calmettes, G., John, S.A., Weiss, J.N., Ribalet, B., Hexokinase-mitochondrial interactions regulate glucose metabolism differentially in adult and neonatal cardiac myocytes. J. Gen. Physiol. 142 (2013), 425–436.
153. 2+ in the regulation of cellular energetics. Biochemistry 51 (2012), 2959–2973.
154. [154] Abo Alrob, O., Lopaschuk, G.D., Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation. Biochem. Soc. Trans. 42 (2014), 1043–1051.
155. [155] Lazar, H.L., Buckberg, G.D., Manganaro, A.J., Becker, H., Maloney, J.V. Jr., Reversal of ischemic damage with amino acid substrate enhancement during reperfusion. Surgery 88 (1980), 702–709.
156. [156] Rosenkranz, E.R., Okamoto, F., Buckberg, G.D., Robertson, J.M., Vinten-Johansen, J., Bugyi, H.I., Safety of prolonged aortic clamping with blood cardioplegia III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury. J. Thorac. Cardiovasc. Surg. 91 (1986), 428–435.
157. [157] Wiesner, R.J., Deussen, A., Borst, M., Schrader, J., Grieshaber, M.K., Glutamate degradation in the ischemic dog heart: contribution to anaerobic energy production. J. Mol. Cell. Cardiol. 21 (1989), 49–59.
158. [158] Ghomeshi, H.R., Tian, G., Ye, J., Sun, J., Hoffenberg, E.F., Salerno, T.A., Deslauriers, R., Aspartate/glutamate-enriched blood does not improve myocardial energy metabolism during ischemia-reperfusion: a 31p magnetic resonance spectroscopic study in isolated pig hearts. J. Thorac. Cardiovasc. Surg. 113 (1997), 1068–1080.
159. [159] Lin, K.M., Wenegieme, E., Lu, P.J., Chen, C.S., Yin, H.L., Gelsolin binding to phosphatidylinositol 4,5-bisphosphate is modulated by calcium and pH. J. Biol. Chem. 272 (1997), 20443–20450.
160. 2+, and apoptosis in neonatal cardiomyocytes during metabolic inhibition/recovery. Circ. Res. 82 (1998), 1139–1144.
161. [161] Huang, C., Yitzhaki, S., Perry, C.N., Liu, W., Giricz, Z., Mentzer, R.M. Jr., Gottlieb, R.A., Autophagy induced by ischemic preconditioning is essential for cardioprotection. J. Cardiovasc. Transl. Res. 3 (2010), 365–373.
162. [162] Shahbazian, M.D., Grunstein, M., Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem 76 (2007), 75–100.
163. [163] McBrian, M.A., Behbahan, I.S., Ferrari, R., Su, T., Huang, T.W., Li, K., Hong, C.S., Christofk, H.R., Vogelauer, M., Seligson, D.B., et al. Histone acetylation regulates intracellular pH. Mol. Cell 49 (2013), 310–321.
164. [164] Galdieri, L., Vancura, A., Acetyl-CoA carboxylase regulates global histone acetylation. J. Biol. Chem. 287 (2012), 23865–23876.
165. [165] Canto, C., Jiang, L.Q., Deshmukh, A.S., Mataki, C., Coste, A., Lagouge, M., Zierath, J.R., Auwerx, J., Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11 (2010), 213–219.
166. [166] Muller, F.L., Liu, Y., Van Remmen, H., Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 279 (2004), 49064–49073.
167. [167] Quinlan, C.L., Treberg, J.R., Perevoshchikova, I.V., Orr, A.L., Brand, M.D., Native rates of superoxide production from multiple sites in isolated mitochondria measured using endogenous reporters. Free Radic. Biol. Med. 53 (2012), 1807–1817.
168. [168] Perevoshchikova, I.V., Quinlan, C.L., Orr, A.L., Gerencser, A.A., Brand, M.D., Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria. Free Radic. Biol. Med. 61 (2013), 298–309.
169. [169] Robinson, A.D., Ramanathan, K.B., McGee, J.E., Newman, K.P., Weber, K.T., Oxidative stress and cardiomyocyte necrosis with elevated serum troponins: pathophysiologic mechanisms. Am. J. Med. Sci. 342 (2011), 129–134.
170. [170] Jian, C., Hou, T., Yin, R., Cheng, H., Wang, X., Regulation of superoxide flashes by transient and steady mitochondrial calcium elevations. Sci. China Life Sci. 57 (2014), 495–501.
171. [171] Aplenc, R., Blanco, J., Leisenring, W., Davies, S., Relling, M., Robison, L., Sklar, C., Stovall, M., Bhatia, S., Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS). ASCO Annu. Meet. Proc., 2006, 9004.
172. [172] Gauthier Laura, D., Greenstein Joseph, L., O'Rourke, B., Winslow Raimond, L., An integrated mitochondrial ROS production and scavenging model: implications for heart failure. Biophys. J. 105 (2013), 2832–2842.
173. [173] Sun, J., Murphy, E., Protein S-nitrosylation and cardioprotection. Circ. Res. 106 (2010), 285–296.
174. [174] Piantadosi, C.A., Regulation of mitochondrial processes by protein S-nitrosylation. Biochim. Biophys. Acta 1820 (2012), 712–721.
175. [175] Ozawa, K., Komatsubara, A.T., Nishimura, Y., Sawada, T., Kawafune, H., Tsumoto, H., Tsuji, Y., Zhao, J., Kyotani, Y., Tanaka, T., et al. S-nitrosylation regulates mitochondrial quality control via activation of parkin. Sci. Rep., 3, 2013, 2202.
176. [176] Catalá, A., Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157 (2009), 1–11.
177. [177] Hudson, E.K., Hogue, B.A., Souza-Pinto, N.C., Croteau, D.L., Anson, R.M., Bohr, V.A., Hansford, R.G., Age-associated change in mitochondrial DNA damage. Free Radic. Res. 29 (1998), 573–579.
178. [178] de Souza-Pinto, N.C., Eide, L., Hogue, B.A., Thybo, T., Stevnsner, T., Seeberg, E., Klungland, A., Bohr, V.A., Repair of 8-oxodeoxyguanosine lesions in mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice. Cancer Res. 61 (2001), 5378–5381.
179. [179] Cheng, Y., Ren, X., Gowda, A.S., Shan, Y., Zhang, L., Yuan, Y.S., Patel, R., Wu, H., Huber-Keener, K., Yang, J.W., et al. Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. Cell Death Dis., 4, 2013, e731.
180. [180] Grollman, A.P., Moriya, M., Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet. 9 (1993), 246–249.
181. [181] Michikawa, Y., Mazzucchelli, F., Bresolin, N., Scarlato, G., Attardi, G., Aging-Dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286 (1999), 774–779.
182. [182] Mouli, P.K., Twig, G., Shirihai, O.S., Frequency and selectivity of mitochondrial fusion are key to its quality maintenance function. Biophys. J. 96 (2009), 3509–3518.
183. [183] Garcia-Prat, L., Martinez-Vicente, M., Perdiguero, E., Ortet, L., Rodriguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A.L., et al. Autophagy maintains stemness by preventing senescence. Nature 529 (2016), 37–42.
184. [184] Linton, P.J., Gurney, M., Sengstock, D., Mentzer, R.M. Jr., Gottlieb, R.A., This old heart: cardiac aging and autophagy. J. Mol. Cell. Cardiol. 83 (2015), 44–54.
185. [185] Grimmel, M., Backhaus, C., Proikas-Cezanne, T., WIPI-mediated autophagy and longevity. Cells 4 (2015), 202–217.
186. [186] Madeo, F., Zimmermann, A., Maiuri, M.C., Kroemer, G., Essential role for autophagy in life span extension. J. Clin. Invest. 125 (2015), 85–93.
187. [187] Chen, Y.F., Kao, C.H., Chen, Y.T., Wang, C.H., Wu, C.Y., Tsai, C.Y., Liu, F.C., Yang, C.W., Wei, Y.H., Hsu, M.T., et al. Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev. 23 (2009), 1183–1194.
188. [188] Wang, C.H., Kao, C.H., Chen, Y.F., Wei, Y.H., Tsai, T.F., Cisd2 mediates lifespan: is there an interconnection among Ca(2)(+) homeostasis, autophagy, and lifespan?. Free Radic. Res. 48 (2014), 1109–1114.
189. 2+ homeostasis. Hum. Mol. Genet. 23 (2014), 4770–4785.
190. [190] Aldridge, J.E., Horibe, T., Hoogenraad, N.J., Discovery of genes activated by the mitochondrial unfolded protein response (mtUPR) and cognate promoter elements. PLoS One, 2, 2007, e874.
191. [191] Haynes, C.M., Ron, D., The mitochondrial UPR—protecting organelle protein homeostasis. J. Cell Sci. 123 (2010), 3849–3855.
192. [192] Mottis, A., Jovaisaite, V., Auwerx, J., The mitochondrial unfolded protein response in mammalian physiology. Mamm. Genome 25 (2014), 424–433.
193. [193] He, H., Chen, M., Scheffler, N.K., Gibson, B.W., Spremulli, L.L., Gottlieb, R.A., Phosphorylation of mitochondrial elongation factor Tu in ischemic myocardium: basis for chloramphenicol-mediated cardioprotection. Circ. Res. 89 (2001), 461–467.
194. [194] Huttlin, E.L., Jedrychowski, M.P., Elias, J.E., Goswami, T., Rad, R., Beausoleil, S.A., Villen, J., Haas, W., Sowa, M.E., Gygi, S.P., A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143 (2010), 1174–1189.
195. [195] Sajid, A., Arora, G., Gupta, M., Singhal, A., Chakraborty, K., Nandicoori, V.K., Singh, Y., Interaction of mycobacterium tuberculosis elongation factor tu with GTP is regulated by phosphorylation. J. Bacteriol. 193 (2011), 5347–5358.
196. [196] Alexander, C., Bilgin, N., Lindschau, C., Mesters, J.R., Kraal, B., Hilgenfeld, R., Erdmann, V.A., Lippmann, C., Phosphorylation of elongation factor tu prevents ternary complex formation. J. Biol. Chem. 270 (1995), 14541–14547.
197. [197] Koc, E.C., Koc, H., Regulation of mammalian mitochondrial translation by post-translational modifications. Biochim. Biophys. Acta (BBA)—Gene Regul. Mech. 1819 (2012), 1055–1066.
198. [198] Guo, B., Zhai, D., Cabezas, E., Welsh, K., Nouraini, S., Satterthwait, A.C., Reed, J.C., Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423 (2003), 456–461.
199. [199] Zapala, B., Kaczynski, L., Kiec-Wilk, B., Staszel, T., Knapp, A., Thoresen, G.H., Wybranska, I., Dembinska-Kiec, A., Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties. Pharmacol. Rep. 62 (2010), 767–777.
200. [200] Hashimoto, Y., Suzuki, H., Aiso, S., Niikura, T., Nishimoto, I., Matsuoka, M., Involvement of tyrosine kinases and STAT3 in humanin-mediated neuroprotection. Life Sci. 77 (2005), 3092–3104.
201. [201] Paharkova, V., Alvarez, G., Nakamura, H., Cohen, P., Lee, K.W., Rat Humanin is encoded and translated in mitochondria and is localized to the mitochondrial compartment where it regulates ROS production. Mol. Cell. Endocrinol. 413 (2015), 96–100.
202. [202] Lee, C., Zeng, J., Drew, B.G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S.J., Mehta, H., Hevener, A.L., de Cabo, R., et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 21 (2015), 443–454.
203. [203] Zarse, K., Ristow, M., A mitochondrially encoded hormone ameliorates obesity and insulin resistance. Cell Metab. 21 (2015), 355–356.
204. [204] Fuku, N., Pareja-Galeano, H., Zempo, H., Alis, R., Arai, Y., Lucia, A., Hirose, N., The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity?. Aging Cell 9 (2015), 921–923.
205. [205] Lee, C., Wan, J., Miyazaki, B., Fang, Y., Guevara-Aguirre, J., Yen, K., Longo, V., Bartke, A., Cohen, P., IGF-I regulates the age-dependent signaling peptide humanin. Aging Cell 13 (2014), 958–961.
206. [206] Gomez-Duran, A., Pacheu-Grau, D., Lopez-Gallardo, E., Diez-Sanchez, C., Montoya, J., Lopez-Perez, M.J., Ruiz-Pesini, E., Unmasking the causes of multifactorial disorders: oXPHOS differences between mitochondrial haplogroups. Hum. Mol. Genet. 19 (2010), 3343–3353.
207. [207] Krzywanski, D.M., Moellering, D.R., Westbrook, D.G., Dunham-Snary, K.J., Brown, J., Bray, A.W., Feeley, K.P., Sammy, M.J., Smith, M.R., Schurr, T.G., et al. Endothelial cell bioenergetics and mitochondrial DNA damage differ in humans having african or west eurasian maternal ancestry. Circ. Cardiovasc. Genet. 9 (2016), 26–36.
208. [208] Kenney, M.C., Chwa, M., Atilano, S.R., Pavlis, J.M., Falatoonzadeh, P., Ramirez, C., Malik, D., Hsu, T., Woo, G., Soe, K., et al. Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS One, 8, 2013, e54339.
209. [209] Kenney, M.C., Chwa, M., Atilano, S.R., Falatoonzadeh, P., Ramirez, C., Malik, D., Tarek, M., Caceres-del-Carpio, J., Nesburn, A.B., Boyer, D.S., et al. Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions. Hum. Mol. Genet. 23 (2014), 3537–3551.
210. [210] van der Walt, J.M., Nicodemus, K.K., Martin, E.R., Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Haines, J.L., Koller, W.C., Lyons, K., et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72 (2003), 804–811.
211. [211] Appleyard, G.D., Forsyth, G.W., Kiehlbauch, L.M., Sigfrid, K.N., Hanik, H.L., Quon, A., Loewen, M.E., Grahn, B.H., Differential mitochondrial DNA and gene expression in inherited retinal dysplasia in miniature Schnauzer dogs. Invest. Ophthalmol. Vis. Sci. 47 (2006), 1810–1816.
212. [212] Hwang, S., Kwak, S.H., Bhak, J., Kang, H.S., Lee, Y.R., Koo, B.K., Park, K.S., Lee, H.K., Cho, Y.M., Gene expression pattern in transmitochondrial cytoplasmic hybrid cells harboring type 2 diabetes-associated mitochondrial DNA haplogroups. PLoS One, 6, 2011, e22116.
213. [213] Lin, C.S., Lee, H.T., Lee, S.Y., Shen, Y.A., Wang, L.S., Chen, Y.J., Wei, Y.H., High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines. Int. J. Mol. Sci. 13 (2012), 11228–11246.
214. [214] Earp, M.A., Brooks-Wilson, A., Cook, L., Le, N., Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk. BMC Res. Notes, 6, 2013, 425.
215. [215] Kaipparettu, B.A., Ma, Y., Park, J.H., Lee, T.L., Zhang, Y., Yotnda, P., Creighton, C.J., Chan, W.Y., Wong, L.J., Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PLoS One, 8, 2013, e61747.
216. [216] Tiao, M.M., Liou, C.W., Huang, L.T., Wang, P.W., Lin, T.K., Chen, J.B., Chou, Y.M., Huang, Y.H., Lin, H.Y., Chen, C.L., et al. Associations of mitochondrial haplogroups b4 and e with biliary atresia and differential susceptibility to hydrophobic bile acid. PLoS Genet., 9, 2013, e1003696.
217. [217] Kenney, M.C., Chwa, M., Atilano, S.R., Falatoonzadeh, P., Ramirez, C., Malik, D., Tarek, M., Del Carpio, J.C., Nesburn, A.B., Boyer, D.S., et al. Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases. Biochim. Biophys. Acta 1842 (2014), 208–219.
218. [218] Malik, D., Hsu, T., Falatoonzadeh, P., Caceres-del-Carpio, J., Tarek, M., Chwa, M., Atilano, S.R., Ramirez, C., Nesburn, A.B., Boyer, D.S., et al. Human retinal transmitochondrial cybrids with J or H mtDNA haplogroups respond differently to ultraviolet radiation: implications for retinal diseases. PLoS One, 9, 2014, e99003.
219. [219] Fetterman, J.L., Zelickson, B.R., Johnson, L.W., Moellering, D.R., Westbrook, D.G., Pompilius, M., Sammy, M.J., Johnson, M., Dunham-Snary, K.J., Cao, X., et al. Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochem. J. 455 (2013), 157–167.